Best Prostatectomy urologists: TOP 113 doctors

He completed his medical education in Hacettepe University Faculty of Medicine (English) in 1995. Between 1995-2000, he completed his specialization in Urology at Dokuz Eylül University Department of Urology.

After his specialization, he worked as a urology specialist at Bayındır State Hospital, Karşıyaka State Hospital, Kemalpaşa State Hospital.
After his specialty education, he continued his vocational education by participating in many different educations, courses and congresses. He received different educations such as endourology courses, PNL - RIRS (closed kidney stone surgeries) course, CİSED training (Association of Sexual Health Institute). He made frequent speeches in congresses, television programs and social media, especially in recent times. He is the member of Turkish Urology Association, Urological Surgery Association and European Urology Association.

Op. Dr. Tansu Turgut is fluent in English and his level of German is intermediate.

Laparoscopic Kidney Cancer

• Kidney Cysts
• Kidney Duct Stenosis Operations
• Holmium Laser Closed (Percutaneous / Flexible-RIRS) Kidney Stone Surgery
• Laser Endoscopic Ureteral Stone Surgery
• Radical Cystectomy Ileal Bladder (Artificial Bladder) Surgery
• Closed Bladder Cancer Surgery (TUR-M)
• Laser Closed Bladder Cancer and Bladder Stone Surgery
• Laparoscopic Prostate Cancer Surgery
• Endoscopic Prostate Treatment (Prostate treatment with laser and plasma kinetic technology TUR-P, TURIS, BiVAP, HOLEP)
• Testicular Cancer Treatments
• Urinary Incontinence Treatments
• Varicocele and Infertility Treatments
• Undescended Testicle
• Vesicoureteral Reflux Treatments
• Hipospadias (Prophet's Sunnah) Circumcision
• One-piece, two-piece, three-piece transverse-longitudinal Penile Prosthesis Implantation in the erection problem (impotence) (happiness stick)
  *REVERSE VASECTOMY*

As a urology specialist providing medical services, Prof. Dr. Hasan Biri graduated from Ankara University Faculty of Medicine in 1987. He started his residency in urology at Gazi University Hospital in 1987 and completed his specialization in 1992, becoming a urology specialist. Dr. Biri completed his compulsory service between 1993-1995. In 1995, he was appointed as an assistant professor at Gazi University Faculty of Medicine. Between 1997-1998, he participated in research in many areas of uro-oncology such as radical prostatectomy and radical cystectomy at the University of Southern California Kneed Norris Uro-oncology Center, and was involved in many clinical practices. He successfully passed the associate professorship exam in 1998 and continued his education and training activities as an associate professor at Gazi University. Between 2000-2003, he served as the head of urology and chief physician at Gazi Ankara Hospital. In 2004, he became a professor at Gazi University Faculty of Medicine. Throughout his academic career, he has published over 80 national and international publications and presented papers. As the founding president of Koru Healthcare Group, Prof. Dr. Hasan Biri currently provides medical services to his patients at Özel Koru Ankara Hospital. Prof. Dr. Hasan Biri is particularly specialized in robotic surgery, and his medical interests include:

• Uro-oncology

· Prostate Cancer

· Bladder Cancer

· Kidney Cancer

· Testicular Cancer

• Andrology

• Robotic Surgery (Prostate, Bladder, Kidney, Renal Artery Stenosis)

• Endourology

• Benign Prostatic Hyperplasia

• Kidney Stone Disease

• Infertility.

El Dr. Yair Muñoz Contreras es Especialista en urología Egresado de la Universidad Autónoma de México. Cursó su especialidad en el Centro Médico Nacional “20 de Noviembre” del Instituto de Seguridad y Servicios Sociales para los trabajadores del estado (ISSSTE), realizó estudios de posgrado en cirugía laparoscópica & robótica y andrología. 

Profesional con más de 12 años de experiencia al cuida de la salud masculina y femenina

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.

Prof. Semih Ayan, MD Fellow of the European Board of Urology Urology Department VM Medical Park Florya Hospital, Istanbul Dr. Ayan graduated from Medical School in 1991 and completed his urology education in 1997.

 At the beginning of his carrier, he was a post doctorate research fellow at the Department of Urology of Harvard Medical School, Children’s Hospital in Boston (1999-2000). He studied the effect of partial ureteral obstruction to the kidney in early developmental stage in an experimental animal fetus model. 

This study provided a significant contribution to a complicated issue of pediatric urology and was cited many times by its successors. He became associate professor of urology in 2004 and was appointed as a professor of urology in 2009. 

He was accepted as a clinical fellow in Minimal Invasive Urologic Oncology at the Department of Surgery, Section of Urology at the University of Chicago (2014-2015).

 He worked in an intense oncology program mainly concentrated on robotic surgery of prostate and kidney cancer. Because of this background, he is mainly interested in urologic oncology and pediatric urology. 

The primary portion of his daily practice consist of kidney cancer, prostate cancer, bladder cancer, neonatal hydronephrosis, ureteropelvic junction obstruction, urine reflux to kidney, hypospadias and undescended testis. 

Because of its prevalence in Turkey, Prof. Ayan has a huge experience with urinary stone disease and he is doing large number of endoscopic and percutaneous surgeries for kidney, ureter and bladder stones. 

Prof. Ayan holds United States Medical License and European Board of Urology Certificate. He is a member of AUA, EAU and Turkish Urologic Surgery and Urologic Oncology Societies.

List of International Scientific Publications; 

1. Ayan S, Yildirim S, Ucar C, Sarioglu Y, Gültekin EY, Butuner C. Corporal reactivity to adenosine and prostaglandin E1 in alloxan-induced diabetic rabbit corpus cavernosum and the effect of insulin therapy. BJU Int, 83: 108-12, 1999.

 2. Yildirim S, Ayan S, Sarioglu Y, Gültekin EY, Butuner C. The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes. BJU Int, 83: 679-85, 1999. 

3. Ayan S, Kaloglu C, Gökce G, Kılıcarslan H, Gültekin EY. Effect of insulin therapy to diabetic cystopathy: urodynamic and histological findings in a rabbit model. Sc J Urol Nephrol, 33: 392-5, 1999. 

4. Yildirim S, Ayan S, Sarioglu Y, Gültekin Y, Uma S. Does diabetes mellitus affect the progress of tolerance to isosorbide dinitrate (ISDN) in corporal tissue? Nitric Oxide: Biology and Chemistry, 4: 29- 34, 2000. 

5. Ayan S, Sarioglu Y, Yildirim S, Gokce G, Bagcıvan I. Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum. BJU Int, 87(3):265-8, 2001.

 6. Ayan S, Gokce G, Kılıcarslan H, Kaya K, Gultekin EY. An unusual cause of urinary incon tinence: urethral coitus. Sc J Urol Nephrol, 35:254, 2001. 

7. Yildirim S, Simsek R, Ayan S, Gokce G, Sarıoğlu Y, Safak C. Relaxant effect of some benzothiazolinone dervatives on isolated rabbit corpus cavernosum. Urol Res, 29:182-5, 2001.

 8. Ayan S, Roth JA, Freeman MR, Bride SH, Peters C. Partial ureteral obstruction dysregulates the RAS in the fetal sheep. Urology, 58: 301-6, 2001.

 9. Kılıcarslan H, Ayan S, Gokce G, Kaya K, Gultekin EY. Cranial blind ending branch of a bifid ureter. Int Urol Nephrol, 32: 635-6, 2001.

 10. Gokce G, Kılıcarslan H, Ayan S, Yıldız E, Kaya K, Gultekin EY. Adenomatoid tumors of testis and epididym: a report of two cases. Int Urol Nephrol, 32:677-80, 2001.

 11. Ayan S, Gokce G, Kılıcarslan H, Ozdemir O, Yildiz E, Gultekin EY. K-RAS mutation in transitional cell carcinoma of urinary bladder. Int Urol Nephrol, 33:363-67, 2001. 

12. Bulut HE, Onarlıoglu B, Kaloglu C, Özdemir Ö, Ayan S. Effects of experimental diabetes and insulin treatment on rabbit renal morphology: a quantitative and qualitative study. Turk J Med Sci, 31: 209-16, 2001. 

13. Kılıcarslan H, Gokce G, Ayan S, Gultekin EY, Arıkan Y, Hocaoglu S. Fournier’s gangrene: a report of 20 cases. T Klin J Med Res 19:55-58, 2001. 

14. Gokce G, Kılıcarslan H, Ayan S, Tas F, Akar R, Kaya K, Gultekin EY. Genitourinary tuberculosis: A review of 174 cases. Scand J Infect Dis, 34: 338-40, 2002.

 15. Kilicarslan H, Yildirim S, Bagcivan I, Ayan S, Sarac B, Sarioglu Y. Effect of chronic renal failure (CRF) on purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int 90(6):596-600, 2002.

 16. Bagcivan I, Gokce G, Ayan S, Yildirim S, Sarac B, Kilicarslan H, Sarioglu Y. Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.Int J Urol.;9(11):641-4; discussion 645, 2002.

 17. Bagcivan I, Kilicarslan H, Sarac B, Gokce G, Yildirim S, Ayan S, Sarioglu Y. The evaluation of the effects of renal failure on erectile dysfunction in a chronic renal failure (CRF) rabbit model. BJU Int.;91(7):697-701, 2003

 18. Kilicarslan H, Guvenal T, Ayan S, Gokce G, Cetin A, Gultekin Y. Comparison of outcomes of three different surgical techniques performed for stress urinary incontinence. Int J Urol.;10(3):126- 30, 2003.

 19. Kaya S, Poyraz O, Gökçe G, Kılıçarslan H, Kaya K and Ayan S. Role of Genital Mycoplasmata and Other Bacteria in Urolithiasis. Scand J Infect Dis, 35:315-317,2003.

 20. Kilicarslan H, Gokce G, Ayan S, Atalar M, Kaya S, Kaya K, Gultekin Y. A case of hydatid disease: urinary retention due to isolated retrovesical hydatid cyst in a boy. Scand J Infect Dis, 35 :408-410, 2003.

 21. Gokce G, Kaya K, Kılıcarslan H, Tas F, Ayan S, Yıldız E, Gultekin E Y. Epidermoid cyst in the renal pelvis. Int Urol Nephrol;35(1):9-10, 2003. 

22. Kilicarslan H, Gokce G, Ayan S, Guvenal T, Kaya K, Gultekin EY. Predictors of outcome after in situ anterior vaginal wall sling surgery. Int Urogynecol J Pelvic Floor Dysfunct ;14(5):339-41, 2003.

 23. Kilicarslan H, Gokce G, Kaya K, Ayan S, Gultekin YE. Surgical treatment of penil fractures. Ulus Travma Derg.;9(1):54-6, 2003. 

24. Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze F, Gultekin EY. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int. 2004 ;93(7):1087-93. 

25. Gokce G, Topsakal K, Ayan S, Kilicarslan H, Gokce SF, Gultekin EY. Case report: Nonobstructive giant urethral stone with two safety pins. Int Urol Nephrol. 2004;36(1):65-6. 

26. Kaya K, Ayan S, Gokce G, Kılıcarslan H, Yildiz E, Gultekin EY. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma. Scand J Urol Nephrol. 38 :1-5,2004.

 27. Ayan S, Kaya K, Topsakal K, Kılıçarslan H, Gokce G, Gültekin Y. Efficacy of tolterodine as a firstline treatment for non-neurogenic voiding dysfunction in children. BJU Int. 96(3):411-4, 2005.

 28. Kaya K, Gokce G , Kaya S, Kilicarslan H, Ayan S, Gultekin EY. Isolated renal and retropertoneal hydatid cysts: a report of 23 cases. Trop Doct. 2006 Oct;36(4):243-6.

 29. Candan F, Ayan S, Tas F, Gokce G, Elagoz S. Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int, 25(6):475-7, 2005. 

30. Silig Y, Pinarbasi H, Gunes S, Ayan S, Bagci H, Cetinkaya O. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest, 24(1):41-5, 2006.

 31. Tanzer F, Ozgur A, Bardakci F, Cankorkmaz L, Ayan S. Analysis of a 1-year-old cystinuric patient with recurrent renal stones. Int J Urol. 13(10):1347-9, 2006.

 32. Kilicarslan H, Ayan S, Vuruskan H, Gokce G, Gultekin EY.Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int Urol Nephrol. 2006;38(3-4):537-41. 

33. Ayan S, Topsakal K, Gokce G, Gultekin EY.Efficacy of combined anticholinergic treatment and behavioral modification as a first line treatment for nonneurogenic and nonanatomical voiding dysfunction in children: a randomized controlled trial. J Urol. 2007 Jun;177(6):2325-8; discussion 2328-9. 

34. Ozdemir O, Gul E, Kilicarslan H, Gokce G, Beyaztas FY, Ayan S, Sezgin I.SRY and AZF gene variation in male infertility: a cytogenetic and molecular approach. Int Urol Nephrol. 2007;39(4):1183-9.

 35. Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int. 2008 Mar;101(6):758-64. 

36. Kenan Kaygusuz, Gokhan Gokce, Iclal Ozdemir Kol, Semih Ayan and Sinan Gursoy. Efficacy of Preventive Analgesia with Tramadol or Lornoxicam for Percutaneous Nephrolithotomy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. Current Therapeutic Research 68(4), 205-216, 2007.

 37. Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimaroglu C, Gultekin Y.A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy: a randomized controlled trial. Anesth Analg. 2008 Jan;106(1):114-9.

 38. Gokce G, Karboga H, Yildiz E, Ayan S, Gultekin Y. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on apoptotic changes in contralateral testis following unilateral testicular torsion. Int Urol Nephrol. 2008;40(4):989-95.

 39. Ozdemir, O (Ozdemir, Oztuerk); Yildiz, E (Yildiz, Esin); Ayan, S (Ayan, Semih); Gul, E (Gul, Eylem)1; Gokce, G (Gokce, Goekhan); Yildiz, F (Yildiz, Fazilet)1; Koksal, B (Koksal, Binnur)1; Goze, F (Goze, Fahrettin); Gultekin, EY (Gultekin, E. Yener). Epigenetic alterations and oncogenes mutations in urinary bladder carcinomas.CHROMOSOME RESEARCH. 2009, Volume: 17 Supplement: 1 Pages: 171-171 

40. Eskicorapci SY, Türkeri L, Karabulut E, Cal C, Akpinar H, Baltaci S, Baykal K; Turkish Validation Study Group of Kattan Preoperative Nomogram, Kattan MW, Ozen H. Collaborators: Yildirim A, Yazici S, Divrik RT, Ozkardeş H, Koşan M, Kurtuluş FO, Büyükalpelli R, Mungan A, Lekili M, Sahin H, Günlüsoy B, Ayan S, Bozlu M. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Urooncology Society. Urology. 2009 Dec;74(6):1289-95.

 41. Ozdemir O, Yildiz S, Ayan S, Gül E, Gokce G, Yildiz F, Koksal B. Promoter hypermethylation of tissue specific tumor supressor genes and point mutation in K-ras, c-myc proto-oncogenes in urinary (transitional cell) bladder carcinoma. Health. 2010; 2(8):850-856. 

42. Türkeri L, Tanıdır Y, Çal Ç, Özen H, Şahin H; Collaborators :Kaya C, Karaman İ, Şengör F, Alkibay T, Sözen S, Büyükalpelli R, Can C, Kuyumcuoğlu U, Albayrak S, Abay E, Soyupak B, Tansuğ Z, Fazlıoğlu A, Gültekin Y, Ayan S, Gümüş E, Lekili M, Dillioğlugil Ö, Özer G, Uygur C, Akpınar H. Comparison of the efficacy of single or double intravesical epirubicin instillation in the early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized multicenter study. Urol Int. 2010;85(3):261-5.

 43. Kuzgunbay B, Yaycioglu O, Soyupak B, Atay Kayis A, Ayan S, Yavascaoglu I, Cal C, Beduk Y; Turkish Study Group of Public Awareness in Testicular Cancer Public awareness of testicular cancer and self-examination in Turkey: A multicenter study of Turkish Urooncology Society.Urol Oncol. 2011 Mar 22. Epub ahead of print] 

44. Biçer H, Korgali E, Gökçe G, Ayan S, Yıldırım S, Gültekin EY. Contractile responses of urinary bladder in an experimental model of chronic renal failure. Bosn J Basic Med Sci. 2012 Nov;12(4):219- 23.

 45. Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Jpn J Clin Oncol. 2013 Jan;43(1):63-8.

 46. Erden Y, Korgalı E, Dundar G, Ayan S, Gokce G, Yildirim S, Gultekin EY. In-vitro effects of PDE5 inhibitor and statin treatment on the contractile responses of experimental MetS rabbit's cavernous smooth muscle. Arch Ital Urol Androl. 2014 Mar 28;86(1):33-8.

Prof. Dr. Fatih Kurtuluş is a Urologist and FEBU (Fellow of European Board of Urology) who graduated from Istanbul University, Cerrahpasa Faculty of Medicine (English), in 1997. He has experience in the fields of endourology and urooncology and has been a professor of Urology since 2018. He has been involved in various organizations and research projects and has published various articles in international refereed journals. He is also a member of various Associations such as the European Association of Urology, Endourological Society, Turkish Association of Urology, and Urooncology Association.

Dr. Sılay is an experienced pediatric urologist practicing in Turkey.

Specialty

Assoc. Prof. Selçuk Sılay specializes in robotic surgery for urology conditions in children.

Dr. Selçuk Sılay has provided over:

• 300 pediatric laparoscopic surgeries
• 100 pediatric robotic surgeries
• 300 closed kidney stone surgeries in children.

Work experience

• Since 2018 – Urologist in Memorial Bahçelievler Hospital and Memorial Ataşehir Hospital
• 2017-2018 – Pediatric urology robotic surgery specialist in Mehmet Akif Ersoy Training and Research Hospital
• 2016-2018 – Head of Pediatric Urology Department in Istanbul Medeniyet University Göztepe Training and Research Hospital
• 2011-2016 – Head of Pediatric Urology Department at the Bezmialem Foundation University
• 2009 – Urology Specialist in Diyarbakir Bismil State Hospital
• 2006-2007 – Urology and Robotic Surgery Specialist.

Education

• 1997-2003 – Ankara University Medical School – Degree in general medicine
• 2003 – Baylor College of Medicine (USA) – Training in urology
• 2004-2009 – Istanbul Şişli Hamidiye Etfal Education And Research Hospital – Training in urology
• 2006-2007 – Baylor College of Medicine (USA) – Internship in urology
• 2014-2015 – Texas Children's Hospital (USA) – Pediatric Urology Robotic Surgery Training (USA).

Awards

• 2016 Young Academician of the Year Award by the 24th National Urology Congress in Cyprus
• 2018 Crystal Matula Award as European Academician of the Year.

Scientific activity

Prof. Selçuk Sılay provides research in robotic surgery in children. Has written over 80 articles.

Membership in organizations

• The Turkish Society of Pediatric Urology
• The European Association of Urology
• The European Society for Paediatric Urology
• The Turkish Association of Urology.

Dr. Ilker Tinay is an Urological Oncologist with expertise in Minimal Invasive Surgery, Neo-Bladder Reconstruction, and Urological Cancer. He has a Bachelor Degree from Istanbul University and Residency in Urology from Marmara University, and speaks English and German. He is a member of the American College of Surgeons and European Association of Urology, and holds multiple board positions.

Assoc. Prof. Dr. Cenk Acar completed his medical education at Ankara University Faculty of Medicine and his urology residency at Gazi University Faculty of Medicine, Department of Urology. He worked as an assistant professor at Pamukkale University Faculty of Medicine, Department of Urology between June 2009 and November 2012. Between May 2012 and November 2012, he worked as a fellow in robotic and laparoscopic surgery in urologic cancers for 6 months in the Urology Department of “The Netherland Cancer Institute-AVL hospital”. He started to work at Acıbadem Ankara Hospital in November 2012. In September 2014, he completed the necessary academic qualifications and received the title of “Associate Professor”. After working in a private hospital in Ankara between 2015-2020, he continued his services in his private practice in Ankara until 2020 when he started Hisar Intercontinental Hospital.

In 2015, he was the chairman of the organizing committee of the first course on ‘Fluorescence Imaging in Urological Surgery’ in the field of urology in Turkey. In the following years, he chaired many urology and multidisciplinary courses on ICG fluorescence imaging under the umbrella of Urology Associations. In 2017, for the first time in Turkey, he started to apply Bipolar Prostate Enucleation in benign prostate enlargement in his clinic. Later, he started to use his increasing experience in surgeries such as HOLEP and THUFLEP.

In his career, Dr. Acar, who is especially interested in Urological Cancers, Urinary System Stones, HOLEP, THUFLEP, Endourology, and Robotic and Laparoscopic Urological Surgeries, has carried out many successful operations. He has performed over 500 urological cancer surgeries, over 250 HOLEP surgeries, countless endoscopic stone surgeries, and numerous robotic and laparoscopic surgeries.

FIELDS OF MEDICAL INTEREST

• Localized Prostate Cancer Treatments
• Quality of Life in Urological Cancers
• Sentinel Lymph Node Dissections in Prostate Cancer
• Intraoperative Fluorescence Imaging Techniques in Robotic and Laparoscopic Urological Surgery
• Prostate Enucleations in BPH (HOLEP, BIPOLEP, THULEP)
• Urinary System Stone Disease

Professor Schatzl is an outstanding urologist and andrologist, specializing in men's health issues such as sexually communicable diseases, premature ejaculation, infertility, vasectomy, erectile dysfunction, urinary tract infections, stone disease, incontinence, irritable bladder, bedwetting, and urological check-ups. He has received numerous awards and has extensive experience in teaching, management, and quality assurance. He is highly qualified to treat any urological and andrological afflictions.

Dr. Ismael Avila Iniguez is a certified General Surgeon and Urologist who graduated from the Medical Faculty of the Autonomous University of Guadalajara with honors and has performed over 3,000 Urological and Oncological surgical procedures. He is a member of various associations and has been recognized for his work in organ transplant units and cancer care. He regularly attends seminars both in the US and Mexico.

Marital Status : He is married, his wife is an ophthalmologist, and he is the father of two sons, aged 27 (Medical doctor) and 20 (Student).

Educational Status

1988 Uludağ University Faculty of Medicine / Bursa

1982 Kabataş Boys' High School / Istanbul

1979 Göztepe Secondary School / Istanbul

1976 Harun Reşit Primary School / Istanbul

Institutions he works for

2020 Biruni University Hospital, Head of Urology Department / ISTANBUL
2017 Yeni Yüzyıl University Gaziosmanpaşa Hospital, Head of Urology Department / ISTANBUL

2016 Taksim Training and Research Hospital Urology Clinic Education and Administrative Supervisor / Istanbul

2009 Bağcılar Training and Research Hospital Urology Clinic Chief / Istanbul

2007 International Hospital, Yeşilköy / Istanbul

2007 Ankara Training and Research Hospital 2nd Urology Clinic / Ankara

2001 Military Service, Marshal Fevzi Çakmak Military Hospital / Erzurum

1999 Bergama State Hospital / Izmir

1997 Ankara Training and Research Hospital Specialization Program / Ankara

1992 Izmit State Hospital / Izmit

 

diplomas

2011 Professorship

2006 Associate Professorship

1997 Urology Specialist

1988 Doctor of Medicine

Associations and organizations of which he is a member

European Association of Urology

Turkish Urology Association

Northern Marmara Urology Association

Endourology Association

Nuhoğlu Foundation

Scientific Publications

Author of over 100 publications, presentations and book chapters, 58 of which are international.

Accepting patients in the Urology medical unit of Florya Hospital, Prof. Dr. Semih Ayan completed his education at Sivas Cumhuriyet University Faculty of Medicine in 1997 and received the title of Urology Specialist. In 1999, he became a Postdoctoral Fellow in Pediatric Urology at Harvard University; He became Associate Professor of Urology in 2003 and Professor of Urology in 2009. In 2015, he completed his Minimal Invasive Urological Oncology (Clinical Fellow) studies at the University of Chicago and crowned his professional education and experience with international studies.

In the field of Urological Oncology, which is one of the physician's areas of interest, surgical treatment of prostate cancer, bladder cancer and kidney tumors provides a significant increase in the survival rate and the chance of surviving cancer. In the field of Pediatric Urology, which is another area of interest, congenital anomalies such as renal outflow stenosis, urinary reflux to the kidney and hypospadias are corrected by using innovative surgical applications and a lifelong contribution is provided to the patients.

Medical equipment required for medical diagnosis, treatment and surgical treatment to be given in the areas specified in our urology units, laparoscopic surgeries and all kinds of equipment suitable for the use of new surgical techniques are available in our hospital. With the treatment and operations performed in our hospitals by making use of the best facilities offered by medical technology, a significant increase in the quality of life is achieved while the patients are healed.

prof. Dr. Semih Ayan received almost all of his medical education and certificates from the leading institutions of America and Europe, and gained deep knowledge and international experience in many advanced specialties of urology. prof. Dr. Among the trainings and certificates Ayan has received internationally;

American Medical License (USML)

Pediatric Urology Fellow (1999-2000/Boston, USA)

Urological Oncology Fellow (2014-2015/USA).

Assist. Op.Dr.Oğuzhan Parlakkılıç graduated from Atatürk University Faculty of Medicine in 2001.

He started his specialization in the urology clinic of Taksim Training and Research Hospital in 2002. Having completed his specialization training in 2007, Dr. Oğuzhan Parlakkılıç attended many national and international meetings. He has studies in andrology, endourology and urooncology.

Between 2007 and 2009, he completed his duty of public service obligation at Sivelek State Hospital.

Between 2009 and 2010, he worked as a urology specialist in the General Command of Mapping Dispensary.